30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Orchard Therapeutics PLC (ORTX)

Track

Stock chart
Ticker: ORTX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Gaspar Bobby
Chief Executive Officer
1 purchase — total 11,085 USD
Buy 1 Apr 2022
Value US$4,938,045.63 | Price 402.07 | Shares 87,480
Buy 1 Apr 2022
Value US$431,704.51 | Price 192.68 | Shares 27,819
Sale 5 Feb 2021
Value US$7,138,829.90 | Price 6.98 | Shares 1,022,755
Sale 5 Feb 2021
Value US$7,138,829.90 | Price 6.98 | Shares 1,022,755
Buy 24 Sep 2020
Value US$2,182,037.47 | Price 4.61 | Shares 473,327
Buy 21 Aug 2020
Value US$46,119.26 | Price 4.51 | Shares 10,226
Buy 21 Aug 2020
Value US$252,490.24 | Price 4.64 | Shares 54,416
Buy 20 Aug 2020
Value US$20,860.25 | Price 4.61 | Shares 4,525
Buy 20 Aug 2020
Value US$267,868.66 | Price 4.61 | Shares 58,106
Buy 19 Aug 2020
Value US$42,082.50 | Price 4.65 | Shares 9,050
Buy 19 Aug 2020
Value US$258,906.76 | Price 4.69 | Shares 55,204
Buy 18 Aug 2020
Value US$213,575.28 | Price 4.72 | Shares 45,249
Buy 17 Aug 2020
Value US$39,033.90 | Price 4.74 | Shares 8,235
Buy 14 Aug 2020
Value US$61,766.94 | Price 4.74 | Shares 13,031
Buy 12 Aug 2020
Value US$77,219.34 | Price 4.74 | Shares 16,291
Buy 10 Aug 2020
Value US$31,966.77 | Price 4.71 | Shares 6,787
Buy 10 Aug 2020
Value US$69,207.50 | Price 4.75 | Shares 14,570
Planned sale 2 Mar 2020
Value US$63,973.00 | Price 13.00 | Shares 4,921
Sale 2 Jan 2020
Value US$74,308.20 | Price 13.55 | Shares 5,484
Sale 2 Jan 2020
Value US$117,377.73 | Price 13.41 | Shares 8,753
Sale 2 Jan 2020
Value US$74,308.20 | Price 13.55 | Shares 5,484
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-04-05 2022-04-01 B Purchase
0.6
Gaspar Bobby

Chief Executive Officer

Executive Director
87,480 +6.2%
402.07
US$4,938,046 		87,480 +6.2% 402.07 US$4,938,046
2022-04-04 2022-04-01 B Purchase
1.4
THOMAS FRANK E

See Remarks

Officer
27,819 -46.8%
192.68
US$431,705 		27,819 -46.8% 192.68 US$431,705
2021-02-10 2021-02-05 S Sale
3.5
FMR LLC

See Remark 1

Large shareholder
71,349 -30.5%
427.46
US$3,464,358 		71,349 -30.5% 427.46 US$3,464,358
2021-02-10 2021-02-05 S Sale
3.5
FMR LLC

See Remark 1

Large shareholder
1,022,755 -16.7%
6.98
US$7,138,830 		1,022,755 -16.7% 6.98 US$7,138,830
2020-11-06 2020-09-24 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
473,327 +5.0%
4.61
US$2,182,037 		473,327 +5.0% 4.61 US$2,182,037
2020-11-06 2020-08-21 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
10,226 +0.1%
4.51
US$46,119 		10,226 +0.1% 4.51 US$46,119
2020-11-06 2020-08-21 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
54,416 +0.6%
4.64
US$252,490 		54,416 +0.6% 4.64 US$252,490
2020-11-06 2020-08-20 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
4,525 +0.0%
4.61
US$20,860 		4,525 +0.0% 4.61 US$20,860
2020-11-06 2020-08-20 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
58,106 +0.6%
4.61
US$267,869 		58,106 +0.6% 4.61 US$267,869
2020-11-06 2020-08-19 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
9,050 +0.1%
4.65
US$42,082 		9,050 +0.1% 4.65 US$42,082
2020-11-06 2020-08-19 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
55,204 +0.6%
4.69
US$258,907 		55,204 +0.6% 4.69 US$258,907
2020-11-06 2020-08-18 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
45,249 +0.5%
4.72
US$213,575 		45,249 +0.5% 4.72 US$213,575
2020-11-06 2020-08-17 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
8,235 +0.1%
4.74
US$39,034 		8,235 +0.1% 4.74 US$39,034
2020-11-06 2020-08-14 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
13,031 +0.1%
4.74
US$61,767 		13,031 +0.1% 4.74 US$61,767
2020-11-06 2020-08-12 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
16,291 +0.2%
4.74
US$77,219 		16,291 +0.2% 4.74 US$77,219
2020-11-06 2020-08-10 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
6,787 +0.1%
4.71
US$31,967 		6,787 +0.1% 4.71 US$31,967
2020-11-06 2020-08-10 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
14,570 +0.2%
4.75
US$69,208 		14,570 +0.2% 4.75 US$69,208
2020-03-04 2020-03-02 PlS Planned sale
0.6
Gaspar Bobby

See Remarks

Executive Director
4,921 -1.4%
13.00
US$63,973 		4,921 -1.4% 13.00 US$63,973
2020-01-06 2020-01-02 S Sale
3.5
FMR LLC

See Remark 1

Large shareholder
5,484 -0.1%
13.55
US$74,308 		5,484 -0.1% 13.55 US$74,308
2020-01-06 2020-01-02 S Sale
3.5
FMR LLC

See Remark 1

Large shareholder
8,753 -0.1%
13.41
US$117,378 		8,753 -0.1% 13.41 US$117,378
2020-01-06 2020-01-02 S Sale
3.5
FMR LLC

See Remark 1

Large shareholder
5,484 -0.1%
13.55
US$74,308 		5,484 -0.1% 13.55 US$74,308
Explore more

More insider trading research around Orchard Therapeutics PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America